Simultaneous Structural and Functional Imaging of the Retinal Pigment Epithelium
Progression of age-related macular degeneration (AMD) coincides with structural changes to the eye. Currently, clinicians and researches use visible light and histological sectioning to study these changes, but are limited to detections of only fairly large structures and lack necessary information associated with the disease. We propose a new paradigm in light microscopy to detect both changes to the eye’s structure as well as functional abnormalities associated with AMD. Currently, this detection method is unknown and unavailable to researchers and clinicians. We propose to investigate the viability of this technique for studying AMD.
In this proposal, we investigate the possibility of vivo imaging studies for age-related macular degeneration (AMD) and ocular diseases in general. While many of the pathognomonic changes of AMD, such as drusen and alterations in retinal pigment epithelium (RPE) physiology, are documented by traditional light or fluorescent microscopy, the molecular mechanism that cause disease onset remains unclear and is best illuminated through longitudinal studies of live animal disease models. Therefore, there is a vital need for dynamic monitoring of living cellular processes, so-called functional imaging, at the subcellular level that would allow for real-time monitoring of the initiation and progression of AMD. We hypothesize that coherent anti-Stokes Raman spectroscopy (CARS), a chemically specific multiphoton spectroscopic technique, can track the onset and progression of AMD by monitoring drusen formation in intact eyes.
Important functional information, such as metabolic states or molecular interactions that promote AMD pathology, can only by studied in vivo. Compared to currently used clinical and nonclinical imaging, CARS microscopy is a relatively young technology. Nonetheless, due to its inherent capability for in vivo diagnostics, its potential impact is enormous. A natural progression from our study, if successful, would be construction of economically viable systems for studying the pathognomonic changes of AMD in live animals using the CARS modality.
Mice that lack the anti-oxidant enzyme Sod1 develop drusen, thickened Bruch’s membrane, and choroidal neovascularization characteristic of AMD. Here, we will examine our hypothesis that CARS can be used to non-invasively and non-destructively study the onset and progression of AMD in Sod1-/- mouse.
About the Researcher
First published on: July 9, 2014
Last modified on: March 2, 2017